Esophageal Cancer PDX Models

Esophageal cancer is the 6th most common cause of cancer related deaths which drives a need for a better understanding of the underlying mechanisms behind the disease through preclinical models. Patient derived xenograft (PDX) models provide a true representation of the human heterogeneity and can be used to better understand these mechanisms in relation to the development of new therapies. CrownBio has a large selection of well characterized Esophageal cancer PDX models, including models with EGFR amplification. More

Patient-derived xenografts (PDX) offer the most translational preclinical model for efficacy screening in cancer drug development. Derived directly from patient tumors and never adapted to grow in vitro, PDX models reflect the heterogeneity and diversity of the human patient population. PDX give you an accurate, predictive model of how your treatment will perform, well before entering into expensive clinical trials.
CrownBio’s HuPrime® PDX collection well characterized for pathology, growth characteristics, and are also genetically/genomically annotated for gene expression, gene copy number, mutations, and fusions.

MODEL ID CANCER TYPE SUBTYPE models per page
ES0026 Esophageal Cancer ESCC VIEW MODEL Details
ES0042 Esophageal Cancer ESCC VIEW MODEL Details
ES0110 Esophageal Cancer ESCC VIEW MODEL Details
ES0136 Esophageal Cancer ESCC VIEW MODEL Details
ES0141 Esophageal Cancer ESCC VIEW MODEL Details
ES0147 Esophageal Cancer ESCC VIEW MODEL Details
ES0148 Esophageal Cancer ESCC VIEW MODEL Details
ES0159 Esophageal Cancer ESCC VIEW MODEL Details
ES0168 Esophageal Cancer ESCC VIEW MODEL Details
ES0172 Esophageal Cancer ESCC VIEW MODEL Details